Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Alnylam Pharmaceuticals (ALNY): Q3 EPS of -$0.38 misses by $0.07. Revenue of $16.8M (-20% Y/Y)...

  • Monday, November 5, 2012, 4:03 PM ET
    Alnylam Pharmaceuticals (ALNY): Q3 EPS of -$0.38 misses by $0.07. Revenue of $16.8M (-20% Y/Y) in-line. (PR)
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)
Latest Earnings Articles
More Latest Articles »